VIDA Insights thumbnail 1
VIDA Insights thumbnail 2
VIDA Insights thumbnail 3
VIDA Insights thumbnail 4
VIDA Insights thumbnail 5
VIDA Insights thumbnail 6
VIDA Insights thumbnail 7
VIDA Insights thumbnail 8
VIDA Insights thumbnail 9

Key Features

  • High density tissue quantification by lobe
  • Hyperion View (tMPR)
  • Low density tissue quantification by lobe
  • Lung disease biomarkers
  • Lung (lobe) volume quantification
  • Scan suitability quality check
  • Trachea analysis and quanitification

General Information

Product name

VIDA Insights

Company

Subspeciality

Chest

Modality

CT

Disease targeted

COPD, interstitial lung disease (ILD), emphysema, COVID-19

Main task

Not specified

Technical Specifications

Population

All Chest CT scans

Patient population age

Not specified

Input

Non-contrast

Input format

DICOM

Output

Quantified Values, Novel Visualizations, Quick Flag Diagrams

Output format

DICOM SC

Integration

Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform

Deployment

Cloud-based, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker)

Trigger for analysis

Automatically, Right after the image acquisition

Processing time

1 - 10 minutes

Regulatory Information

CE Certification

Pathway:

MDD

Class:

Class IIa

Verified by Health AI Register
FDA Certification

Pathway:

510(k) cleared

Class:

Class II

Verified by Health AI Register

Other certifications

Not specified

Market Presence

On market since

12-2019

AI Platforms

Bayer Pharmaceuticals, Blackford Analysis, Intelerad, Nuance, TeraRecon

Resellers

IBM Watson Health

Countries present

Not specified

Paying clinical customers

Not specified

Research/test users

Not specified

Pricing Information

Pricing model

Subscription

Based on

Total imaging volume

Evidence & Research

Other Articles

Other

View

Relationships Between Airflow Obstruction and Quantitative CT Measurements of Emphysema, Air Trapping, and Airways in Subjects With and Without Chronic Obstructive Pulmonary Disease

Other

View

Quantitative computed tomography of the lungs and airways in healthy nonsmoking adults

Other

View

Total Airway Count on Computed Tomography and the Risk of Chronic Obstructive Pulmonary Disease Progression. Findings from a Population-based Study

Other

View

Quantitative CT of Interstitial Lung Disease

Other

View

SPIROMICS Protocol for Multicenter Quantitative Computed Tomography to Phenotype the Lungs

Source: vendor | First published: Feb 28, 2020 | Last updated: Jul 9, 2025